000			02227 a2200709 4500
005			20250517121500.0
264		0	_c20171009
008			201710s 0 0 eng d
022			_a1476-5551
024	7		_a10.1038/leu.2016.282 _2doi
040			_aNLM _beng _cNLM
100	1		_aUy, G L
245	0	0	_aDynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy. _h[electronic resource]
260			_bLeukemia _c04 2017
300			_a872-881 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBone Marrow _xpathology
650	0	4	_aClonal Evolution _xgenetics
650	0	4	_aEpigenesis, Genetic _xdrug effects
650	0	4	_aExome
650	0	4	_aFemale
650	0	4	_aGenes, p53
650	0	4	_aHigh-Throughput Nucleotide Sequencing
650	0	4	_aHistone Deacetylase Inhibitors _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aLeukemia, Myeloid, Acute _xdiagnosis
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMutation
650	0	4	_aMyelodysplastic Syndromes _xdiagnosis
650	0	4	_aPolymorphism, Single Nucleotide
650	0	4	_aRemission Induction
650	0	4	_aTreatment Outcome
650	0	4	_aTumor Burden
700	1		_aDuncavage, E J
700	1		_aChang, G S
700	1		_aJacoby, M A
700	1		_aMiller, C A
700	1		_aShao, J
700	1		_aHeath, S
700	1		_aElliott, K
700	1		_aReineck, T
700	1		_aFulton, R S
700	1		_aFronick, C C
700	1		_aO'Laughlin, M
700	1		_aGanel, L
700	1		_aAbboud, C N
700	1		_aCashen, A F
700	1		_aDiPersio, J F
700	1		_aWilson, R K
700	1		_aLink, D C
700	1		_aWelch, J S
700	1		_aLey, T J
700	1		_aGraubert, T A
700	1		_aWestervelt, P
700	1		_aWalter, M J
773	0		_tLeukemia _gvol. 31 _gno. 4 _gp. 872-881
856	4	0	_uhttps://doi.org/10.1038/leu.2016.282 _zAvailable from publisher's website
999			_c26515060 _d26515060